Back to Authors

Tencer, T.

https://orcid.org/0000-0002-7539-664X

A5070271568 | I145311141

Mayo Clinic

Alnylam Pharmaceuticals (United States)

Citations 1

Kidney Survival in Patients with Primary Hyperoxaluria Type 1 Treated with Lumasiran Compared with Historical Controls

Journal of the American Society of Nephrology | December 1, 2025 | Volume: 36 | Issue: 10S | Pages: No page available

10.1681/asn.2025d7va7dp6